Olema Pharmaceuticals, Inc. (OLMA): Capital Expenditures

Annual figures by period end, from SEC filings.

$159.0K
Year ended 2024-12-31
-53.4%
3-year compound annual growth
$1.57M2020-12-31: $56.0K2021-12-31: $1.57M2022-12-31: $363.0K2024-12-31: $159.0K$159.0K
2020-12-31 Capital Expenditures (USD) 2024-12-31
Period endedCapital ExpendituresChange YoYSource filing
2024-12-31$159.0Kn/a2026-03-16, From 2024-01-01
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31$363.0K-77.0%2024-03-11, From 2022-01-01
2021-12-31$1.57Mn/m2023-03-09, From 2021-01-01
2020-12-31$56.0Kn/a2022-02-28, From 2020-01-01